Table 2 Markers of inflammation in response to eccentric strength exercise. Data are means (±SE). |
|
Control Trial |
Omega-3 Trial |
Between Trials P value |
Arm Volumetry, L |
Baseline |
2.032 (.144) |
1.997 (.141) |
|
48h Follow-up |
2.060 (.145) |
2.019 (.145) |
|
Change |
.029 (.016) |
.022 (.024) |
.74 |
Within group P value |
.11 |
.38 |
|
Arm Circumference, cm |
Baseline |
28.6 (1.0) |
29.1 (1.0) |
|
48h Follow-up |
29.2 (1.1) |
29.4 (1.0) |
|
Change |
.6 (.2) |
.3 (.2) |
.45 |
Within group P value |
.01 |
.15 |
|
Skin Temperature,°C |
Baseline |
31.6 (.2) |
31.9 (.2) |
|
48h Follow-up |
31.3 (.2) |
31.9 (.3) |
|
Change |
-.3 (.2) |
.0 (.3) |
.34 |
Within group P value |
.09 |
1.0 |
|
Soreness, Weighted, cm on VAS* |
Baseline |
.2 (.1) |
.1 (.0) |
|
48h Follow-up |
6.4 (.7) |
5.1 (.7) |
|
Change |
6.1 (.7) |
5.0 (.7) |
.02 |
Within group P value |
<.0001 |
<.0001 |
|
Soreness, Palpated, cm on VAS* |
Baseline |
.2 (.1) |
.4 (.3) |
|
48h Follow-up |
6.2 (.7) |
4.9 (.7) |
|
Change |
6.0 (.6) |
4.5 (.8) |
.11 |
Within group P value |
<.0001 |
<.0001 |
|
Soreness, Fully Extended, cm on VAS* |
Baseline |
.3 (.1) |
.2 (.1) |
|
48h Follow-up |
7.8 (.8) |
6.6 (.8) |
|
Change |
7.5 (.7) |
6.4 (.8) |
.004 |
Within group P value |
<.0001 |
<.0001 |
|
|
Within trial P values are from paired t-tests comparing baseline and 48h follow up values. Between trial P-values are from paired t-tests comparing change-scores in the control trial to change scores in the omega-3 trial. |
|